Back to results
US 7,064,141 B1Granted
Method for preventing, treating or inhibiting development of simple retinopathy and preproliferative retinopathy
AssigneeTakeda Pharmaceutical Company Limited
InventorsShizue Nakagawa, Yasutaka Nagisa, Hitoshi Ikeda
Life of this patent
Estimating the term…
Abstract
To provide a pharmaceutical composition for preventing, treating or development-inhibiting simple retinopathy or preproliferative retinopathy, comprising a compound having angiotensin II antagonistic activity, or a salt thereof.
Claims2
A method for improving retinal potential or retinal edema in a mammal in need thereof, which comprises administering to the mammal an effective amount of a compound having angiotensin II antagonistic activity, wherein the compound having angiotensin II antagonistic activity is
- 2-ethoxy-1-[[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylic acid, a prodrug thereof or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.